Hong Kong stock exchange’s new regime permitting companies with dual-class shares to list came into effect on April 30. We asked four experts about the pros and cons of this change.
The city's exchange operator will accept applications from pre-revenue biotech companies and issuers with dual-class shares from next Monday, despite lingering concerns.
AsianInvestor reveals the winning custodians, index provider, law firm, auditor and compliance adviser in the latest batch of its annual Asset Management awards.
Transparency rules can be a useful way to empower investors, but more does not always mean better. It's all about getting the right balance.
Analysts believe China's insurance regulator's scoring of how well insurers manage their assets and liabilities could prove costly for some, but should improve the industry's health.
Anbang’s fall should serve as a serious warning for other Chinese insurers looking to take advantage of insurance sales to help fund asset acquisitions.